Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAINBO: Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features, TransPORTEC Platform Trials - MMRd-GREEN.

NCT05255653 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT05255653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAINBO: Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features, TransPORTEC Platform Trials - MMRd-GREEN.
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
November 11, 2021
Completion date
January 1, 2031
Enrollment
316 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer